Document Detail

Cardiac manifestations other than valvulopathy in antiphospholipid syndrome: long-time echocardiography follow-up study.
MedLine Citation:
PMID:  24131635     Owner:  NLM     Status:  Publisher    
AIM: Non-valvular cardiac disease in the antiphospholipid syndrome (APS) has been scanty studied. We wanted to assess the prevalence and evolution of left myocardial disease, pulmonary hypertension and intracardiac thrombi in a cohort of APS patients.
METHOD: A total of 53 patients with APS, either primary (n = 34, 64%) or associated to lupus (n = 19, 36%) and 20 controls were included. Initial transthoracic echocardiography assessment was performed in patients at diagnosis, with echocardiography controls performed along mean follow-up of 12 years. Prevalence of myocardial disease in APS cohort was assessed taking into account primary risk factors (hemodynamically significant valvular disease, systemic hypertension, diabetes, alcoholism, myocardial infarction or myocarditis), the same as for pulmonary hypertension (severe left ventricular dysfunction or chronic lung disease).
RESULTS: Left myocardial disease had a prevalence of 3.8% (2/53 patients), not different from controls (P = 0.12). Both patients had diastolic dysfunction grade I that maintained stability throughout echocardiographic follow-up period. Pulmonary hypertension had a prevalence of 11.3% (6/53 patients), not different from controls (P = 0.12); all cases were related to pulmonary embolism. Patients diagnosed with pulmonary hypertension in baseline maintained stable pressures throughout follow-up in the absence of new thrombosis. Intracardiac thrombi had a prevalence of 1.8% (1/53 patients), not different from controls (P = 0.4), without changes along echocardiographic follow-up.
CONCLUSION: Pulmonary hypertension is the most prevalent non-valvular cardiac manifestation in APS, with an evolution associated with thromboembolic disease, while left myocardial disease and intracardiac thrombi would be rare manifestations in APS.
José Pardos-Gea; Gonzalo Avegliano; Arturo Evangelista; Miguel Vilardell; José Ordi-Ros
Related Documents :
3284315 - Short-term effect of coronary artery bypass grafting on the signal-averaged electrocard...
12691375 - A review of the guardian trial results: clinical implications and the significance of e...
12114335 - Angiotensin i-converting enzyme insertion/deletion polymorphism and cardiac mortality a...
2785875 - Risk factors for mortality after primary combined valvular and coronary artery surgery.
10606115 - Electrocardiographic predictive factors of long-term clinical improvement with multisit...
17420995 - Coronary artery fistulas: how to manage them.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2013-10-17
Journal Detail:
Title:  International journal of rheumatic diseases     Volume:  -     ISSN:  1756-185X     ISO Abbreviation:  Int J Rheum Dis     Publication Date:  2013 Oct 
Date Detail:
Created Date:  2013-10-17     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101474930     Medline TA:  Int J Rheum Dis     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
© 2013 Asia Pacific League of Associations for Rheumatology and Wiley Publishing Asia Pty Ltd.
Research Unit for Autoimmune Diseases, Department of Internal Medicine, Vall d'Hebrón University Hospital, Universidad Autónoma de Barcelona, Barcelona, Spain.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Location of transient ectodermal progenitor potential in mouse development.
Next Document:  Reduced fibrosis in recurrent HCV with tacrolimus, azathioprine and steroids versus tacrolimus: rand...